Correlation Between Mangalam Drugs and Hindustan Construction

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mangalam Drugs and Hindustan Construction at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mangalam Drugs and Hindustan Construction into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mangalam Drugs And and Hindustan Construction, you can compare the effects of market volatilities on Mangalam Drugs and Hindustan Construction and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mangalam Drugs with a short position of Hindustan Construction. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mangalam Drugs and Hindustan Construction.

Diversification Opportunities for Mangalam Drugs and Hindustan Construction

0.88
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Mangalam and Hindustan is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Mangalam Drugs And and Hindustan Construction in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hindustan Construction and Mangalam Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mangalam Drugs And are associated (or correlated) with Hindustan Construction. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hindustan Construction has no effect on the direction of Mangalam Drugs i.e., Mangalam Drugs and Hindustan Construction go up and down completely randomly.

Pair Corralation between Mangalam Drugs and Hindustan Construction

Assuming the 90 days trading horizon Mangalam Drugs And is expected to under-perform the Hindustan Construction. But the stock apears to be less risky and, when comparing its historical volatility, Mangalam Drugs And is 2.21 times less risky than Hindustan Construction. The stock trades about -0.07 of its potential returns per unit of risk. The Hindustan Construction is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  3,777  in Hindustan Construction on August 28, 2024 and sell it today you would lose (43.00) from holding Hindustan Construction or give up 1.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Mangalam Drugs And  vs.  Hindustan Construction

 Performance 
       Timeline  
Mangalam Drugs And 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mangalam Drugs And has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Hindustan Construction 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hindustan Construction has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Mangalam Drugs and Hindustan Construction Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mangalam Drugs and Hindustan Construction

The main advantage of trading using opposite Mangalam Drugs and Hindustan Construction positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mangalam Drugs position performs unexpectedly, Hindustan Construction can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hindustan Construction will offset losses from the drop in Hindustan Construction's long position.
The idea behind Mangalam Drugs And and Hindustan Construction pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Money Managers
Screen money managers from public funds and ETFs managed around the world